#United States #New York #Parkinson's Disease #Parkinson's Foundation #Andi Lipstein Fristedt

Parkinson's Foundation Strengthens Leadership with New EVP

The Parkinson's Foundation has recently appointed Andi Lipstein Fristedt as the new Executive Vice President and Chief Strategy and Policy Officer. This strategic decision marks the first time in the foundation's history that such a role will guide the organization’s initiatives, aiming to enhance the community services directed at individuals living with Parkinson's disease (PD).

A Commitment to the Parkinson's Community

As the leading organization dedicated to improving the lives of those affected by Parkinson's disease, the Foundation seeks to make a real difference through a comprehensive approach that includes research funding, assistance in care, and education. Fristedt's role is pivotal in ensuring that these programs are not only aligned with the foundation's goals but also responsive to the dynamic needs of the Parkinson's community.

John L. Lehr, President and CEO of the Parkinson's Foundation, expressed enthusiasm about the new leadership appointment. He stated, “As the Foundation continues to respond to the needs of the Parkinson's community, we are proud to announce the addition of a chief strategy and policy officer.” Fristedt’s extensive experience in health policy is viewed as essential for expanding the Foundation's impact and public affairs initiatives.

An Impressive Background

Andi Lipstein Fristedt comes to the Parkinson's Foundation with nearly two decades of experience in public health policy, having held significant positions within the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). In her previous role at the CDC, she acted as the Deputy Director and Chief Strategy Officer, leading the agency’s engagement in various global health efforts and overseeing critical budget and strategy decisions that engaged lawmakers in Washington.

Her tenure at the FDA involved policies that bolstered medical product regulation and addressed pressing health issues such as tobacco use and food safety. Particularly noteworthy was her leadership in lobbying for significant health legislation, which instrumentally guided the FDA to enhance its authority over non-tobacco nicotine products. Fristedt's initiative to engage with tribal partners to improve health equity further underscores her commitment to the communities she serves.

Vision for the Future

Fristedt shared her aspirations for her role, stating, “I've dedicated my career to driving health for communities and patients across the country and around the globe.” She aims to leverage her leadership experience to foster substantial progress for individuals diagnosed with Parkinson's disease and their families.

The Parkinson's Foundation: A Brief Overview

Founded in 1957, the Parkinson's Foundation has been at the forefront of advancing research and improving care for those affected by Parkinson's disease. Over the years, the foundation has invested more than $474 million in various initiatives aimed at enhancing the quality of life for the Parkinson's community. The foundation not only offers valuable resources and support but also actively drives public awareness and advocacy efforts to address the challenges faced by the community.

With Parkinson's disease affecting approximately one million Americans, the organization's mission is more critical than ever. CDC data indicates that the condition is the second-most common neurodegenerative disease following Alzheimer's and the 14th-leading cause of death in the United States. The progressive condition leads to various motor and non-motor symptoms, with nearly 90,000 new cases diagnosed annually.

As the Parkinson's Foundation embarks on this new chapter with Fristedt’s leadership, its ongoing commitment to advancing research, enhancing care, and serving the Parkinson's community will remain at the forefront of its priorities. Individuals interested in learning more about the Foundation’s efforts can connect through their website or social media platforms.